Based on enhancing the effect of naturally occurring gut hormone Glucagon like peptiede-1 (GLP-1), novel therapeutic agents have been developed and made available in the management of T2DM in the last decade. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.